Akili announced that Eddie Martucci transitioned to the role of board chair, and Matt Franklin has been appointed to serve as president and CEO of the company and as a member of its board of directors, effective October 5. Martucci replaces former board chair, Chamath Palihapitiya, who has resigned from the board, effective October 4. The leadership transition follows the company’s announcement in September that it plans to shift from a prescription to a non-prescription business model. As the company progresses into this next phase. Franklin joined Akili in June 2022 as its president and chief operating officer.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on AKLI:
